Form 4: C4 Therapeutics Chief Medical Officer Reports Routine Share Withholding for Tax Obligations

C4 Therapeutics, Inc.'s Chief Medical Officer, Leonard Reyno, reported the withholding of 7,382 shares of common stock to cover tax obligations related to restricted stock unit vesting.

Summary

• Leonard Reyno, Chief Medical Officer of C4 Therapeutics, Inc. (CCCC), reported a transaction on July 10, 2025.
• The transaction involved the disposition of 7,382 shares of common stock.
• These shares were withheld by the Issuer at a price of $1.99 per share to satisfy tax withholding obligations associated with the vesting and settlement of restricted stock units (RSUs).
• This withholding does not represent a sale by the reporting person.
• Following this transaction, Leonard Reyno beneficially owns 166,382 shares of common stock directly.

Sentiment

Score: 5

Explanation: The document reports a routine administrative transaction (shares withheld for tax obligations) which is neutral in sentiment and does not indicate positive or negative operational or financial performance.

Future Outlook

na

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction, specifically a tax withholding event, and does not provide broader industry context or trends. Such filings are common across all industries for executives receiving equity compensation.

Stakeholder Impact

• Shareholders: Minimal impact as it is a routine administrative transaction for tax purposes, not a discretionary sale by the insider.
• Employees: Reflects standard equity compensation practices for executives.

Key Dates

Keywords

C4 Therapeutics, CCCC, Form 4, Insider Transaction, Leonard Reyno, Chief Medical Officer, Share Withholding, Restricted Stock Units, Tax Obligations, Equity Compensation